By David M. Burd
My recent AoA Post of October 6 revealed the CDC lie that most U.S. flu vaccines have no Thimerosal. In fact the Vaccine Industry has long published a great majority of.50 mL doses have 25 micrograms of ethylmercury (etHg); at the time of my previous Post I had not uncovered what percentage of .25 mL infant/child doses (age 6 months to 3 years) had 12.5 micrograms of etHg. To satisfy myself I kept searching and analyzing the Flu Vaccine Industry Reports from 2009 on, and searched for hard-to-find medical directives on pediatric flu vaccine procedures relevant to the .25 mL dose for ages under 36 months.
For many years the CDC and the Academy of Pediatrics have strongly promoted (fear mongered is also appropriate) American parents to have their infants get two Hg-laden flu shots, the first at 6 months, another shot 4 weeks later. Even worst, premature babies but half the weight of full-term infants (and with much more vulnerable neurological development) are also given these two shots starting 6 months from being born. Thus by seven months, via flu shots, 25 micrograms of etHg are injected into extremely vulnerable infants - the same as for a 200 pound adult
This question arises are these infants receiving shots that are "Thimerosal-free?" The horrific answer is no, and is convincingly proven by the Vaccine Industry's published statistics, and by printed medical instructions to take .25 mL doses from 5 mL multi-dose etHg-preserved vials.
Only since the 2009 -2010 flu season have pediatric Thimerosal-free (TF) .25 mL single-dose syringe doses been produced - but the quantities of such TF doses suppled to the Health Industry have never exceeded .59 percent of entire flu-dose output, and have averaged less than .30 percent (three-tenths of one percent) over the last six years. Since the total flu-dose production has averaged around 150 million doses per year, the annual pediatric TF .25 mL doses available comes to but 450,000.
However, according to years of CDC statistics/surveys close to 67% of American infants age 6 months - 35 months have been getting flu shots. The math is straightforward. For decades U.S. annual births have been very close to 4 million every year; therefore 67% of 4 million babies age 6-7 months getting two shots require 5.33 vaccine doses; 4 million infants age 1 to 2 years require an additional 2.67 million doses, and 4 million young children age 2 years to 3 years require yet another 2,67 million flu-shot does. This comes to 10.67 million doses, but the supply averages only 450,000 .25 mL single-dose syringes. Thus over 10 million Hg-laden flu doses are actually given to babies/kids under 3 years old dictates these 10 million .25 mL pediatric doses must be drawn from 5 mL multi-dose vials preserved with etHg. Then, equally unforgivable and horrific, at 3 years age and every year thereafter, children are injected with adult flu doses (the vast majority having .25 micrograms of etHg) year after year.
As referred to in the title of this Post, even more exposure to etHg comes while in the mother's womb as the CDC et al. strongly pushes/coerces the typical mother-to-be to get her flu shot, and the etHg is passed to her fetus at the MOST fragile time of development - this sounds like the most evil science fiction, but as the saying goes: "truth is stranger than fiction."
It is entirely plausible - if not most probable - the terrible ever-increasing neurological damages (including autism) inflicted on our American babies and children are directly caused by the etHg in pediatric flu shots, and even before they are born. There are many Journal Papers that warn about the toxicity of etHg vaccines while the book Age of Autism by Olmsted and Blaxill leaves no doubt as to etHg's deadliness. I need cite below only two Journal references, along with the Vaccine Industry references. Those interested can easily find them on the Web.
David Burd is 1965 Northwestern University graduate with a degree in Astronautical Sciences & Mechanical Engineering. He began his career in Military Projects, proceeding into civilian innovations such as compact disc technology and optical character recognition. Since 1997 he phased into medical device technology focused mainly on surgical methods and application of surgical energy and protheses and treatments for such as asthma and circulation issues.
References: 1) Annual Flu Vaccine Industry reports (search keywords: "hida influenza vaccine production 2010" (or 2009, 2011, 2012, 2014. 2015, 2016). 2) Journal on Developmental Disabilities, Tomljenovic et al. vol 18, number 1, 2012. 3) Dorea JG Environ Res Nov 3, 152:280-293. 4) CIIS Colorado Immunization Information System Accurate Reconciling Multi-dose Vials Flu Vaccine.